Prurigo Nodularis Clinical Trials

Trevi Protocol TR-11: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy, and Safety Study in Prurigo Nodularis with Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRISM Study) -CURRENTLY ENROLLING

  • clinical trial investigating the use of an oral opioid in patients with moderate to severe prurigo nodularis.

Nalbuphine ER

  • We are now recruiting patients for a clinical trial for patients with at least 10 lesions of PN in at least two anatomical areas. Eligible patients cannot have underlying skin conditions (ie eczema). Enrollment closing soon!